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PEMBANGUNAN KOMPOSIT BIODEGRADASI Mg-Zn/HA MELALUI 
PENGALOIAN MEKANIKAL 
 
ABSTRAK 
 
Kajian ini bertujuan untuk membangunkan bahan logam biodegradasi menggunakan 
pengaloian mekanikal (MA). Magnesium (Mg) adalah calon yang paling menjadi 
tumpuan bagi aplikasi bioperubatan berdasarkan kelebihan sifat-sifatnya berbanding 
bahan bio yang lain. Tetapi kadar degradasi yang cepat dalam persekitaran fisiologi 
menghadkan prestasinya. Oleh itu, Mg telah dialoikan dengan zink (Zn) bagi 
meningkatkan kerintangan kakisan dan mengekalkan integritimekanikal. Dalam 
mencapai sasaran ini, bahan bio berasaskan Mg telah difabrikasi melalui MA diikuti 
dengan pemadatan di bawah 400 MPa dan pensinteran pada 350°C. Empat parameter 
MA iaitu masa pengisaran, kelajuan pengisaran, nisbah berat bola kepada serbuk 
(BPR) dan kandungan Zn telah disiasat. Ketumpatan 1.80 hingga 1.99 g/cm
3
 yang 
setara dengan tulang manusia dan kekerasan mikro yang lebih baik daripada Mg 
tulen (39.30 HV) iaitu antara 53.76 hingga 94.37 HV telah diperolehi. Berdasarkan 
rekabentuk faktorial pecahan (FFD), keadaan MA optimum dalam menghasilkan aloi 
Mg-Zn dicapai dengan menambah 6.5 wt% Zn yang dikisar selama 5 jam pada 200 
rpm dengan 7: 1 BPR. Kekuatan mampatan yang lebih tinggi (249.28 MPa) dan 
kadar kakisan yang lebih rendah (1.13 x10
-2
 mm/y) daripada Mg tulen (178.04 MPa 
dan 13.77 x10
-2 
mm/y) telah diperolehi. Penambahbaikan sifat-sifat tersebut telah 
dicapai dengan menambah 10 wt% HA ke dalam aloi Mg-6.5wt%Zn. Kekuatan 
mampatan (292.33 MPa) dan kadar degradasi (0.72 x10
-2 
mm/y) yang bagus 
diperolehi. Komposit Mg-Zn/HA memberikan bioaktiviti paling tinggi dengan nisbah 
Ca:P sebanyak 1:1.46 diikuti oleh aloi Mg-Zn 1:1.29 memenuhi keperluan 
pemineralan awal tulang iaitu 1:1 kepada 1:1.67. 
xx 
 
DEVELOPMENT OF BIODEGRADABLE Mg-Zn/HA COMPOSITE VIA 
MECHANICAL ALLOYING 
 
ABSTRACT 
 
This work aims to develop biodegradable metallic material using mechanical 
alloying (MA). Magnesium (Mg) is the most highlighted candidate for biomedical 
applications because of its advantageous properties as compared with other 
biomaterials. But a rapid degradation rate in physiological environment limits its 
performance. Hence, Mg was alloyed with zinc (Zn) in order to improve its corrosion 
resistance and sustain its mechanical integrity. In achieving the target, Mg based 
biomaterials were fabricated using MA followed by compaction under 400 MPa and 
sintering at 350 °C. Four MA parameters namely milling time, milling speed, ball-to-
powder-weight ratio (BPR) and Zn content were investigated. The density of 1.80 to 
1.99 g/cm
3
 which is comparable to human bone and improved microhardness of 
53.76 to 94.37 HV as compared to pure Mg (39.30 HV) were attained. By fractional 
factorial design (FFD), an optimized MA condition in producing Mg-Zn alloy was 
achieved by adding 6.5 wt% Zn and milled for 5 hours at 200 rpm with 7:1 BPR. A 
higher compressive strength (249.28 MPa) and lower corrosion rate (1.13x10
-2 
mm/y) than pure Mg (178.04 MPa and 13.77 x10
-2 
mm/y) were acquired. A further 
improvement of those properties was attained by incorporating 10 wt% HA into 
optimized Mg-6.5wt%Zn alloy. An enhanced compressive strength (292.33 MPa) 
and degradation rate (0.72 x10
-2 
mm/y) was attained. Mg-Zn/HA composite provided 
the highest bioactivity due to highest Ca:P ratio of 1:1.46 followed by Mg-Zn alloy 
of 1:1.29 which is in agreement with the required Ca:P ratio of 1:1 to 1:1.67 for 
initial bone mineralization. 
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CHAPTER 1 
INTRODUCTION 
 
1.1   Introduction 
The use of metallic materials for medical implants can be traced back to the 
19
th
 century, leading up to the era when the metal industry began to expand during 
the Industrial Revolution (Kraus et al., 2012). The development of metallic implants 
was primarily driven by the demands for approaches to bone repair, typically internal 
fracture fixation of long bones. However, almost no attempts of implanting metallic 
devices, such as spinal wires and bone pins made from iron, gold or silver, were 
successful until Lister's aseptic surgical technique was implemented in the 1860s 
(Xin et al., 2011). Since then, metallic materials have predominated in orthopaedic 
surgery, playing a major role in most orthopaedic devices, including temporary 
devices (e.g. bone plates, pins and screws) and permanent implants (e.g. total joint 
replacements) (Zeng et al., 2008). 
The conventional metallic implant materials namely titanium (Ti) alloys, 
stainless steels and (Co-Cr) alloys possess excellent mechanical capabilities and 
highly resistance to corrosion (Hermawan et al., 2010; Castellani et al., 2011; 
Anghelina et al., 2013). However, when these conventional alloys are used as 
temporary implant devices, a second surgical procedure is required for the implant 
removal after the traumatized tissues have healed which markedly increases the 
health care cost. Besides, there is an increased risk of local inflammation due to 
potential release of cytotoxic ions as well as the physical irritation due to the rigidity 
of these conventional implants (Li et al., 2012). 
 
2 
 
Currently, the development of new biodegradable metallic biomaterials 
combining excellent strength retention properties and improved biocompatibility for 
several applications such as stents for blood vessels and screws and plates for fixing 
hard tissues are highly desirable (Hort et al., 2010). The main driving force to 
develop biodegradable implants is an elimination of secondary surgical procedure as 
they have ability to biodegrade in the bioenvironment during the implantation 
duration. Hence, the paradigm of metallic implants must be highly inert and 
corrosion resistance has now been challenged by advent of the new class of 
degradable biomaterials (Lei et al., 2012).  
Magnesium (Mg) and its alloys have attracted increasing attention as 
innovative biodegradable materials for temporary orthopaedic implants due to their 
excellent biological performance and biodegradability in bioenvironment. In terms of 
mechanical properties, Mg is well compatible with natural bone. Its density (1.74 
g/cm
3
) and Young‟s modulus (40 - 48 GPa) are closer to those of bone (1.8 - 2.1 
g/cm
3
 and 40 - 57 GPa) than in the case of other currently used biomaterials for 
fixation of fractured bone, like Ti alloys, stainless steels or Co-Cr alloys at 
approximately 100, 180 and 210 GPa respectively (Li et al., 2004; Sudhakar, 2005; 
Gupta and Sharon, 2011). In term of biocompatibility, Mg ions are present in a large 
amount in the human body and they are involved in many metabolic reactions and 
biological mechanisms. The human body usually contains Mg at approximately 35 g 
per 70 kg body weight and the daily demand for Mg is about 375 mg (Gill et al., 
2011). 
An attractive characteristic of Mg due to its corrodibility makes it as a 
potential biodegradable metallic implant. However, the fast degradation rate of Mg in 
human bioenvironment containing chloride anions (Cl
-
) about 100 mmol/l 
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concentration limited its clinical application (Wang et al., 2012). A rapid degradation 
rate during implantation results in a deterioration of its mechanical performance 
which then causes a worst injury to a traumatized hard tissue. Elemental alloying is 
one of the most effective way to improve corrosion resistance as well as mechanical 
properties of Mg. Mg alloys containing aluminium (Al) and rare earth (RE) elements 
showed relatively high strength and good corrosion resistance against sodium 
chloride (NaCl) solution such as AZ61 (Mg-6wt%Al-1wt%Zn) and WE43 (Mg-(3.7-
4.4wt%) Y-(2.4-4.4 wt%) E-0.42wt%Zr) alloys (Gupta and Sharon, 2011). However 
it has been reported that the Al release from Mg alloy into human body could induce 
Alzheimer‟s disease, allergic reaction and neurological disorder (Silva et al., 2004; 
Zhang et al., 2010b). 
The exploration of high strength biodegradable Mg alloys without Al for 
medical implants has gained great attention in the past years and it is still ongoing. In 
certainty, there are only a small number of elements that can be tolerated in human 
body and can also retard the biodegradation of Mg alloys including calcium (Ca), 
manganese (Mn), zinc (Zn) and perhaps very small amount of low toxicity rare earth 
including niobium (Nb) and tantalum (Ta). Zn has been found to be next to Al in 
strengthening effectiveness as an alloying element in Mg. Adding Zn to Mg may 
improve both tensile strength and the corrosion resistance (Yin et al., 2008). 
Biologically, Zn is a necessary microelement and component of many amino acids 
and nucleic acids syntheses of human body. Moreover, Zn is an inexpensive alloying 
element with a potential of accelerating the metabolism of cells and bone healing 
(Jang et al., 2013). Therefore, it is a contributing approach to develop Mg-Zn alloy 
with good corrosion resistance for a temporary bioimplant in biomedical 
applications.  
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Typically, metallic materials including Mg based alloy have been produced 
using conventional liquid state processing such as casting (Zeng et al., 2011; Lei et 
al., 2011; Kubok et al., 2013). However due to some defects that are usually found in 
cast Mg alloy causing poor final properties, further treatments may be required to 
improve the situation. Recently, powder metallurgy (PM) process coupled with 
mechanical alloying (MA) to synthesize Mg based alloys is of growing interest 
(Gonzalez et al., 2012; Patel and Morsi, 2012). This technique is a solid state powder 
metallurgical process in which elemental powders are being alloyed by repeated 
deformation mechanism under frequent mechanical impacts (Suryanarayana, 2001). 
MA is one of the simplest and most economical routes for the fabrication of 
nanocrystalline materials. In addition, MA offers the possibility to scale up the 
quantity of processed material to tonnage amount and be employed for the 
processing of nearly all types of materials (Yadav et al., 2012). This makes MA the 
ideal processing route for small as well as for large scale production of 
nanocrystalline materials.  
Another important point for a biomaterial is the ability of the implant to 
establish bonding with the surrounding bone tissue which is the bioactivity of the 
implant (Khanra et al., 2010). Therefore, it seems necessary to increase the 
bioactivity of Mg based alloys by introducing bioactive materials into the matrix 
(Khalil, 2012). Bioactive ceramic such as hydroxyapatite (HA; C10(PO4)6(OH)2) has 
been widely used as an implant material for hard tissues owing to its excellent 
biocompatibility to human tissues because it has similar structure with the mineral 
part of bone. HA has calcium (Ca) and phosphorus (P) elements in its hexagonal 
structure (Veljovic et al., 2009). These elements present the inorganic of the bone. 
Therefore, strong bonds are spontaneously generated to living bone via an apatite 
